映恩生物正式挂牌港交所

金融界
15 Apr

观点网讯:4月15日,映恩生物Duality Biotherapeutics, Inc.(简称“映恩生物”)在香港联合交易所主板成功挂牌上市。此次IPO全球发售1733.23万股H股,占发行完成后总股份的20.29%,每股下限定价94.60港元,募集资金总额约16.40亿港元,所得款净额约15.13亿港元。映恩生物此次招股公开发售部分获115.14倍认购,国际发售部分获13.52倍认购。映恩生物...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10